Filtered By:
Cancer: Skin Cancer

This page shows you your search results in order of relevance. This is page number 6.

Order by Relevance | Date

Total 49911 results found since Jan 2013.

Hard Copy Durable Patient Cancer Education Materials: Do They Still Matter?
Abstract Traditional hard copy information materials are still present in our cancer clinics. While their actual impact on patient care often goes un-assessed, it is important to understand their role in today’s electronic age where information can easily be obtained from various sources. It has remained the practice in our melanoma clinic to provide an information booklet to all of our new patients. The purpose of this study was to evaluate how useful this booklet was, as well as determine the current resources our patients use to gather cancer information. All patients referred to the clinic in the previous 3...
Source: Journal of Cancer Education - January 22, 2016 Category: Cancer & Oncology Source Type: research

From 'Immoral' Users to 'Sunbed Addicts': The Media-Medical Pathologising of Working-class Consumers and Young Women in Late Twentieth-century England
Soc Hist Med. 2022 Apr 29;35(3):770-792. doi: 10.1093/shm/hkac012. eCollection 2022 Aug.ABSTRACTDrawing on the changing representations of sunbed consumers within everyday entertainment media and national newspapers from the late 1980s to early 1990s, this article will demonstrate how sunbed use was framed, at first, as an 'immoral' working-class activity, and later as a growing addictive threat to white adolescent women. Medical experts had finally confirmed that sunbeds increased the risk of developing skin cancer, and the media had taken this 'public health' matter into their own hands. As this occurred during a backlas...
Source: Medical History - September 2, 2022 Category: History of Medicine Authors: Fabiola Creed Source Type: research

Upstate medical students teach school children to be ‘sun smart’
Medical students in Upstate Medical University’s Dermatology Interest Group are sharing their “sun smart” message with 450 elementary school pupils this month. “We are all extremely excited at the opportunity to raise awareness of the dangers of skin cancer and the importance of proper sun protection starting at an early age,” said group president Nathalie [...]
Source: SUNY Upstate Medical - April 26, 2016 Category: Universities & Medical Training Source Type: news

Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3-month trial.
CONCLUSION: In this multicenter, assessor-blinded trial, the use of a film-forming medical device with sun protection and anti-inflammatory actions was effective in reducing AK lesions and improving the dermoscopy aspect of the target lesion in 86% of treated subjects. A head-to-head trial evaluating the efficacy of this medical device in comparison with diclofenac is warranted to establish if this therapeutic approach could offer additional advantages in term of AK lesions reduction compared to an established topical treatment. (Trial ID: ISRCTN72020277). PMID: 28358282 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - March 31, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research

Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancer.
CONCLUSIONS: In this study, gender, stage, performance status, presence of liver or bone metastases and treatment had an effect on overall survival. PMID: 32512671 [PubMed - as supplied by publisher]
Source: Turkish Journal of Medical Sciences - June 10, 2020 Category: General Medicine Tags: Turk J Med Sci Source Type: research

Incidence, mortality and medical costs of patients hospitalized with melanoma in Spain: a retrospective multicentre observational study.
CONCLUSIONS: The increasing in-hospital incidence of melanoma appeared to reverse in 2014, as did the increasing mortality rate measured in older males. The shift in melanoma in-hospital incidence could respond to the increasing trend to treat patients in primary care settings. Further studies will be required to confirm these trends in order to adapt the healthcare system. PMID: 33591848 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - February 18, 2021 Category: Research Tags: Curr Med Res Opin Source Type: research

Data-Driven Deep Supervision for Medical Image Segmentation
Medical image segmentation plays a vital role in disease diagnosis and analysis. However, data-dependent difficulties such as low image contrast, noisy background, and complicated objects of interest render the segmentation problem challenging. These difficulties diminish dense prediction and make it tough for known approaches to explore data-specific attributes for robust feature extraction. In this paper, we study medical image segmentation by focusing on robust data-specific feature extraction to achieve improved dense prediction. We propose a new deep convolutional neural network (CNN), which exploits specific attribut...
Source: IEE Transactions on Medical Imaging - June 1, 2022 Category: Biomedical Engineering Source Type: research

Private donors enhance melanoma care in the Maritimes
Mrs. Leslie Shaw and her husband, Allan, recently made a $1-million gift to the Dalhousie Medical Research Foundation to improve melanoma diagnosis and treatment in the Maritimes.
Source: Dalhousie University | Medical School News - May 21, 2015 Category: Universities & Medical Training Authors: Dalhousie Medical School Tags: News Source Type: news

Assessment of cetuximab-induced infusion reactions and administration rechallenge at an academic medical center
AbstractCetuximab is approved for treatment of squamous cell carcinoma of the head and neck (SCCHN). Cetuximab is generally well tolerated, but does carry a black box warning for infusion reactions (IRs). Incidence of IR in clinical trials was 15 –20% for all grades and 3–5% for grades III–IV. Retrospective studies reported a higher incidence of all grade IRs and grades III–IV IR in areas of the Southeastern United States. Information regarding rechallenge doses after an IR has not been well described. At our institution, we frequent ly rechallenge on the same day after an initial IR. The primary objective was to d...
Source: Medical Oncology - February 21, 2017 Category: Cancer & Oncology Source Type: research

Research is Changing the Game for Melanoma Treatment
Wilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist and published in Lancet Oncology.
Source: University of Rochester Medical Center Press Releases - January 31, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

OncoSec Medical prices $20m public offering
OncoSec Medical (NSDQ:ONCS) today priced an underwritten public offering of 13,333,334 shares of its common stock at $1.50 apiece. The San Diego, Calif.-based company expects the offering to bring in $20 million to help fund its Phase II melanoma trial, as well as other clinical and R&D activities. Get the full story at our sister site, Drug Delivery Business News. The post OncoSec Medical prices $20m public offering appeared first on MassDevice.
Source: Mass Device - February 1, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Funding Roundup Oncology Pharmaceuticals Wall Street Beat OncoSec Medical Source Type: news

Conjunctival melanoma: A 20-year survey in a comprehensive medical center
Publication date: Available online 14 May 2020Source: Journal of the Formosan Medical AssociationAuthor(s): Pei-Ying Chen, Yi-Lin Liao, Yen-Chang Chu, Yueh-Ju Tsai
Source: Journal of the Formosan Medical Association - May 16, 2020 Category: General Medicine Source Type: research